With reporting season in full swing, there are three companies to talk about today. 1300 Smiles a strong result, and Volpara is making progress is rolling out their Software As A Service platform. Finally, the big news is from Impedimed. They've officially launched their commercial version of their heart failure product called SOZO, which means the product could be available earlier than anticipated. More on all three of these stories in the video below.
Please sign in to comment on this wire.